Experience

Davis Polk advised the representatives of the underwriters in connection with the initial public offering of 40,000,000 units of AEA-Bridges Impact Corp. for aggregate proceeds of $400…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 5,750,000 common shares of Beam Therapeutics Inc. for total gross proceeds of $127…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 23,000,000 units of Climate Change Crisis Real Impact I…

Davis Polk advised Grayscale Investments, LLC, as sponsor, in connection with the registration of the common units of fractional undivided beneficial interest (“Shares”) of Grayscale…

  Davis Polk advised the representatives of the several underwriters in connection with the $96 million initial public offering by Mission Produce, Inc. of 8,000,000 shares of its…

We advised an ad hoc group of lenders on the transaction

Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …

Davis Polk advised the joint bookrunners in connection with the initial public offering by Boa Vista Serviços S.A. and the selling shareholders of 154,650,184 common shares for an…

  Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S debt offering by Carvana Co. of $500 million aggregate principal amount of its 5.625%…

Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Fresnillo plc of 4.250% senior notes due 2050 in the aggregate amount of $850…